Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of Practice Survey: Radiotherapy for Soft Tissue Sarcoma of the Extremities.

Cureus·2020
Same author

Targeted Mass Spectrometry-Based Assays for Relative Quantification of 30 Brain-Related Proteins and Their Clinical Applications.

Journal of proteome research·2018
Same author

Clinical Validation of a Serum Protein Panel (FLNA, FLNB and KRT19) for Diagnosis of Prostate Cancer.

Journal of molecular biomarkers & diagnosis·2018
Same author

Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach.

Journal of proteomics·2018
Same author

Comparison of five cell-free DNA isolation methods to detect the EGFR T790M mutation in plasma samples of patients with lung cancer.

Clinical chemistry and laboratory medicine·2018
Same author

Benign and malignant scientific irreproducibility.

Clinical biochemistry·2018

Related Experiment Video

Updated: Jul 15, 2026

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid
10:23

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid

Published on: December 4, 2017

Proteomics analysis of human amniotic fluid.

Chan-Kyung J Cho1, Shannon J Shan, Elizabeth J Winsor

  • 1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 1L5, Canada.

Molecular & Cellular Proteomics : MCP
|May 15, 2007
PubMed
Summary

Researchers profiled the human amniotic fluid (AF) proteome in normal pregnancies. This comprehensive analysis identified 842 proteins, including known biomarkers, aiding in understanding AF function and discovering new prenatal diagnostic tools.

More Related Videos

Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis
14:48

Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis

Published on: May 8, 2021

Related Experiment Videos

Last Updated: Jul 15, 2026

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid
10:23

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid

Published on: December 4, 2017

Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis
14:48

Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis

Published on: May 8, 2021

Area of Science:

  • Proteomics
  • Biochemistry
  • Maternal-Fetal Medicine

Background:

  • Amniotic fluid (AF) composition reflects fetal physiological status.
  • Understanding AF proteome is crucial for prenatal diagnostics.
  • Previous studies had limited AF proteome coverage.

Purpose of the Study:

  • To profile and analyze the human amniotic fluid (AF) proteome in mid-pregnancy (16-18 weeks).
  • To identify proteins within AF for a better understanding of its functions.
  • To discover novel biomarkers for prenatal diagnosis of fetal abnormalities.

Main Methods:

  • Utilized three distinct fractionation strategies for enhanced AF proteome coverage.
  • Employed two-dimensional LC/MS/MS and LC-SDS-PAGE-LC-MS/MS platforms.
  • Analyzed 16 AF samples from normal pregnancies (16-18 weeks gestation) using mass spectrometry.

Main Results:

  • Identified a comprehensive AF proteome of 842 non-redundant proteins (1,026 unique gene matches).
  • The identified proteome includes established biomarkers for pregnancy complications.
  • Bioinformatic analysis revealed subcellular localization, tissue expression, and functional networks of AF proteins.

Conclusions:

  • The study provides a detailed map of the mid-pregnancy AF proteome.
  • This proteomic dataset enhances understanding of AF functions.
  • The findings support the discovery of novel biomarkers for prenatal diagnosis of fetal conditions.